Latest Breaking News On - Department of medicine at dana farber cancer institute - Page 1 : comparemela.com

Biagio Ricciuti, MD, discusses the need to improve the identification of patients with advanced non–small cell lung cancer that benefit most from immune checkpoint inhibition.

Dana farber cancer instituteUnited statesBiagio ricciutiDepartment of medicine at dana farber cancer instituteInternational associationLung cancerPatients with advanced non small cell lung cancer